Martin Metzenmacher

4PUBLICATIONS
13CO-AUTHORS
Predictive and prognostic markersCancer diagnosisCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jul 21, 2021
Real-world efficacy of docetaxel plus nintedanib after chemo-immunotherapy failure in advanced pulmonary adenocarcinoma.

Martin Metzenmacher, Filippo Rizzo, Kato Kambartel

|May 04, 2021
[The Current Therapy of Asbestos-Associated Malignant Pleural Mesothelioma - An Expert Consensus Paper].

C Aigner, T Brüning, W E E Eberhardt

Pageof 1